of fever, myalgia, anorexia, petechial haemorrhage, easy bruising, occatioal gum bleeding and purpuric rash. There was no history of jaundice and high colour urine.He had abdominal discomfort with anorexia and itching throughout the body. He was anxious looking with average body built, pulse 80/m, blood pressure 130/80 mmHg, no lymphadinopathy, temperature 100 0 F continued in nature, purpur rash in the lower extremities. Some are red, some are black which did not blench on pressure. Systemic examination including respiratory, cardiovascular and endocrine systems also did not reveal any abnormality.
Investigations revealed-Hb 12.5gm/dl, ESR 40 mm 1 st hour, and Tc of WBC 5000/cmm DC of WBC-Neutrophil-68%, Lymphocyte-25%, Monocyte-02%, Eosinophil-05%. Platelet count <35,000 /cumm. Peripheral blood film (PBF) shows thrombocytopenia. Bone marrow examination reveals increased number of megakaryocytes with variable size & shape, serum bilirubin-1.6g/dl, ALT 50 IU, Urea-30 mg/dl, creatinine-1.1gm/dl, BT-prolonged, CTnormal, PT-prolonged, APTT-normal. Patient was initially diagnosed as ITP, then he was treated with steroid 1mg/dl body wt. and other supportive therapy for 4 weeks but patient did not improve.Then patient was again reevaluate by further investigations of viral markers, HIV-1 & 2-negative, Anti HCVnegative, HBsAg-positive, HBeAg-positive, HBv-DNA-positive, albumin globulin ratio altered. Considering all the history, clinical findings& laboratory investigations including, virological markers, finally the patient was diagnosed as a case of auto immune thrombocytopenia purpura (ITP) due to hepatitis B-virus infection.
Discussion:
The occurrence of immune thrombocytopenic purpura (ITP) due to hepatitis B-virus infection is very rare. We suggest that immune thrombocytopenic purpura (ITP) has to be kept in mind in differential diagnosis of hepatitis B-virus infection in any patient presented with history thrombocytopenia in developing country. Thrombocytopenia associated with hepatitis B-virus infection lead to an amelioration in the platelet count. Most cases are refectory thrombocytopenia which may be treated with infusion of IVG or Anti-D and interferon-a. Treatment with corticosteroid is not recommended in HBV infection. 4, 5, 6 Patient was treated by antiviral agent lamivudine. Patient symptomatically improved.His liver function improved after 6 month. Serum ALT level decreased and Albumin level increased. A depovir dipivoxyl-a nucleoside analogues, has recently become available in Bangladesh. This drug is shown to be benefit in chronic HBV patients in the replicative phage and has shown very low rates of resistance after one year of therapy. 7, 8, 9 This may be an alternate to lamivudine. Therapy and its efficacy in patients with decompensated cirrhosis due to chronic HBV needs to be investigated.
